Syndromes caused by chromosomal abnormality | OMIM | Chromosome | |
Phelan McDermid syndrome | 606 232 | 22q terminal deletion or ring chromosome 22 | |
Prader Willi syndrome | 176 270 | 15q11 microdeletion or maternal UPD 15 | |
Thrombocytopenia with absent radius | 274 000 | 1q21.1 microdeletion and RBM8A | |
Turner syndrome | 45,X0 | ||
Velocardiofacial syndrome | 192 430 | 22q11 microdeletion | |
Syndromes caused by single gene fault | OMIM | Gene(s) | |
Autosomal dominant | Noonan/Cardiofaciocutaneous syndrome | 163 950 | PTPN11, RIT1, RAF1, SOS1, KRAS, BRAF, MAP2K1, MAP2K2 plus others |
CHARGE syndrome | 214 800 | CDH7 | |
Microcephaly-chorioretinopathy-lymphoedema-intellectual disability | 152 950 | KIF11 | |
Oculo-dento-digital syndrome | 164 200 | GJA1 | |
Hypotrichosis-lymphoedema-telangiectasia-renal-defect syndrome | 137 940 | SOX18 | |
Ruvalcaba syndrome | 180 870 | PTEN | |
Costello syndrome | 218 040 | HRAS | |
Sotos syndrome | 117 550 | NSD1 | |
Tuberous sclerosis | 191 100 | TSC1, TSC2 | |
Autosomal recessive | Carbohydrate-deficient glycoprotein types 1a, 1b and 1 hour | 212 065, 602 579, 608 104 | PMM2, PM1, ALG8 |
Choanal atresia-lymphoedema | 613 611 | PTPN14 | |
Cholestasis-lymphoedema syndrome (Aagenaes syndrome) | 214 900 | ||
Hennekam-lymphangiectasia-lymphoedema syndrome type 1, 2 and 3 | 235 510 to 616 006 | CCBE1, FAT4, ADAMTS3 | |
Hypotrichosis-lymphoedema-telangiectasia syndrome | 607 823 | SOX18 | |
X linked | Ectodermal dysplasia, anhidrotic, immunodeficiency, osteopetrosis and lymphoedema syndrome | 300 301 | IKBKG (NEMO) |
Fabry disease | 301 500 | GLA | |
Somatic | CLOVES syndrome Macrocephaly capillary malformation | 602 501 | PIK3CA |
Syndromes with no known cause | OMIM | ||
Irons-Bianchi syndrome | 601 927 | ||
Mucke syndrome | 247 440 | ||
Progressive encephalopathy, hypsarrhythmia, optic atrophy | 260 565 | ||
Yellow nail syndrome | 153 300 |
The syndromes are categorised by mode of inheritance. The causal genes or structural variants and OMIM number are indicated where known.